14-day Premium Trial Subscription Try For FreeGet Free
NASDAQ:INFI

Infinity Pharmaceuticals Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0160
+0 (+0%)
At Close: Dec 08, 2023
Chart & Forecast Earnings Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Sep 09, 2023 Buy 768 133 Perkins Adelene Q Common Stock
Sep 12, 2023 Sell 410 196 Perkins Adelene Q Common Stock
Sep 09, 2023 Sell 768 133 Perkins Adelene Q Restricted Stock Unit
Aug 02, 2022 Buy 14 994 Peluso Stephane Common Stock
Aug 02, 2022 Sell 50 000 Peluso Stephane Restricted Stock Unit
Jun 16, 2022 Buy 45 000 Evnin Anthony B Stock Option(right to buy)
Jun 16, 2022 Buy 45 000 Beier David W Stock Option (right to buy)
Jun 16, 2022 Buy 45 000 Gaynor Richard Stock Option(right to buy)
Jun 16, 2022 Buy 45 000 Agresta Samuel Stock Option(right to buy)
Jun 16, 2022 Buy 45 000 Selby Norman C Stock Option(right to buy)
Jun 16, 2022 Buy 45 000 Schwartz Brian Stock Option(right to buy)
Mar 30, 2022 Buy 90 000 Kango Sujay Stock Option (right to buy)
Mar 30, 2022 Buy 0 Kango Sujay
Jan 11, 2022 Buy 576 100 Perkins Adelene Q Stock Option (right to buy)
Jan 11, 2022 Buy 335 000 Bloch Lawrence E Stock Option (right to buy)
Jan 11, 2022 Buy 225 000 Tasker Seth A Stock Option (right to buy)
Jan 11, 2022 Buy 87 027 Peluso Stephane Stock Option(right to buy)
Jan 11, 2022 Buy 87 472 Ilaria Robert Jr. Stock Option(right to buy)
Sep 07, 2021 Buy 60 000 Schwartz Brian Stock Option (right to buy)
Sep 07, 2021 Buy 60 000 Schwartz Brian Stock Option (right to buy)
Sep 07, 2021 Buy 56 250 Schwartz Brian Stock Option (right to buy)
Sep 01, 2021 Buy 300 000 Ilaria Robert Jr. Stock Option (right to buy)
Sep 01, 2021 Buy 0 Ilaria Robert Jr.
Aug 02, 2021 Buy 250 000 Peluso Stephane Stock Options (right to buy)
Aug 02, 2021 Buy 50 000 Peluso Stephane Restricted Stock Unit
Aug 02, 2021 Buy 0 Peluso Stephane Common Stock
Jun 10, 2021 Buy 30 000 Beier David W Stock Option (right to buy)
Jun 10, 2021 Buy 3 061 Beier David W Common Stock
Jun 10, 2021 Buy 30 000 Agresta Samuel Stock Option (right to buy)
Jun 10, 2021 Buy 30 000 Selby Norman C Stock Option (right to buy)
Jun 10, 2021 Buy 10 000 Selby Norman C Stock Option (right to buy)
Jun 10, 2021 Buy 30 000 Gaynor Richard Stock Option (right to buy)
Jun 10, 2021 Buy 3 061 Evnin Anthony B Common Stock
Jun 10, 2021 Buy 30 000 Evnin Anthony B Stock Option (right to buy)
May 14, 2021 Sell 5 000 Selby Norman C Stock Option (right to buy)
May 14, 2021 Buy 5 000 Selby Norman C Common Stock
Feb 17, 2021 Buy 0 Bvf Partners L P/il
Feb 11, 2021 Sell 1 215 491 Bvf Partners L P/il Common Stock, $0.001 par value
Feb 11, 2021 Sell 892 467 Bvf Partners L P/il Common Stock, $0.001 par value
Feb 11, 2021 Sell 152 127 Bvf Partners L P/il Common Stock, $0.001 par value
Jan 22, 2021 Sell 2 821 663 Bvf Partners L P/il Common Stock, $0.001 par value
Jan 22, 2021 Sell 2 458 838 Bvf Partners L P/il Common Stock, $0.001 par value
Jan 22, 2021 Sell 568 019 Bvf Partners L P/il Common Stock, $0.001 par value
Dec 22, 2020 Buy 250 000 Tasker Seth A Stock Option (right to buy)
Dec 22, 2020 Buy 335 000 Bloch Lawrence E Stock Option (right to buy)
Dec 22, 2020 Buy 485 000 Perkins Adelene Q Stock Option (right to buy)
Jun 17, 2020 Buy 30 000 Venuti Michael C Stock Option (right to buy)
Jun 17, 2020 Buy 30 000 Selby Norman C Stock Option (right to buy)
Jun 17, 2020 Buy 10 000 Selby Norman C Stock Option (right to buy)
Jun 17, 2020 Buy 30 000 Beier David W Stock Option (right to buy)
Jun 17, 2020 Buy 30 000 Agresta Samuel Stock Option (right to buy)
Jun 17, 2020 Buy 22 826 Evnin Anthony B Common Stock
Jun 17, 2020 Buy 30 000 Evnin Anthony B Stock Option (right to buy)
Mar 16, 2020 Buy 60 000 Gaynor Richard Stock Option (right to buy)
Mar 16, 2020 Buy 0 Gaynor Richard
Jan 10, 2020 Buy 412 500 Tasker Seth A Stock Option (right to buy)
Jan 10, 2020 Buy 53 538 Tasker Seth A Common Stock
Jan 10, 2020 Buy 83 157 Bloch Lawrence E Common Stock
Jan 10, 2020 Buy 418 750 Bloch Lawrence E Stock Option (right to buy)
Jan 10, 2020 Buy 450 000 Kutok Jeffery Stock Option (right to buy)
Jan 10, 2020 Buy 64 219 Kutok Jeffery Common Stock
Jan 10, 2020 Buy 155 134 Perkins Adelene Q Common Stock
Jan 10, 2020 Buy 606 250 Perkins Adelene Q Stock Option (right to buy)
Oct 16, 2020 Buy 60 000 Agresta Samuel Stock Option (right to buy)
Oct 16, 2019 Buy 0 Agresta Samuel Common Stock
Oct 16, 2019 Buy 81 250 Agresta Samuel Stock Option (right to buy)
Oct 16, 2019 Buy 10 433 Agresta Samuel Stock Option (right to buy)
Jun 13, 2019 Buy 13 125 Evnin Anthony B Common Stock
Jun 13, 2019 Buy 30 000 Evnin Anthony B Stock Option (right to buy)
Jun 13, 2019 Buy 10 000 Selby Norman C Stock Option (right to buy)
Jun 13, 2019 Buy 30 000 Beier David W Stock Option (right to buy)
Jun 13, 2019 Buy 30 000 Venuti Michael C Stock Option (right to buy)
Jun 13, 2019 Buy 100 000 Bloch Lawrence E Stock Option (right to buy)
Jun 13, 2019 Buy 30 000 Kauffman Michael Stock Option (right to buy)
Jun 13, 2019 Buy 242 000 Perkins Adelene Q Stock Option (right to buy)
Jun 13, 2019 Buy 26 250 Berkowitz Jeffrey Common Stock
Jun 13, 2019 Buy 30 000 Berkowitz Jeffrey Stock Option (right to buy)
Jan 04, 2019 Buy 140 000 Tasker Seth A Stock Option (right to buy)
Jan 04, 2019 Buy 335 000 Bloch Lawrence E Stock Option (right to buy)
Jan 04, 2019 Buy 155 000 Kutok Jeffery Stock Option (right to buy)
Jan 04, 2019 Buy 62 596 Agresta Samuel Stock Option (right to buy)
Jan 04, 2019 Buy 243 000 Perkins Adelene Q Stock Option (right to buy)
Dec 13, 2018 Buy 54 461 Bvf Partners L P/il Common Stock, $0.001 par value
Dec 13, 2018 Buy 120 539 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 28, 2018 Buy 100 000 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 21, 2018 Buy 4 119 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 19, 2018 Buy 50 044 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 19, 2018 Buy 733 151 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 19, 2018 Buy 38 001 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 19, 2018 Buy 556 709 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 21, 2018 Buy 581 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 19, 2018 Buy 5 573 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 19, 2018 Buy 81 648 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 15, 2018 Buy 52 400 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 14, 2018 Buy 117 290 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 13, 2018 Buy 41 454 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 15, 2018 Buy 39 074 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 14, 2018 Buy 92 960 Bvf Partners L P/il Common Stock, $0.001 par value
Nov 13, 2018 Buy 562 754 Bvf Partners L P/il Common Stock, $0.001 par value
Oct 01, 2018 Sell 5 000 Perkins Adelene Q Common Stock
INSIDER POWER
-8.782
Last 100 transactions
Buy: 11 236 884 | Sell: 9 346 934 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -8.782.

In total, the insiders bought 11 236 884 and sold 9 346 934 INFI shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Infinity Pharmaceuticals

Infinity Pharmaceuticals Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the tre... INFI Profile

Golden Star

Ticker Date Change Price
SGEN Dec 04 2.74% $213.13
SJM Dec 01 7.10% $111.42
ESS Nov 30 5.93% $213.46
KMX Nov 30 5.13% $63.94
CVNA Nov 30 28.54% $31.32
ATKR Nov 30 4.10% $129.90
ENS Nov 30 4.49% $88.48
THS Nov 30 2.36% $40.71
AMRC Nov 29 12.03% $28.34
CP Nov 29 2.20% $71.32
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT